The PPARγ-activator rosiglitazone does not alter remodeling but increases mortality in rats post-myocardial infarction

Authors
Publication date
Publisher
'Elsevier BV'
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Crossref

      redirect
      Last time updated on 02/01/2020